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ABSTRACT
Neurological manifestations of dengue infection are rare. This review includes data regarding the epidemiology of the
disease, neurological manifestations, pathogenesis, diagnosis and prognosis. It is based on 9 original articles and 10 case
reports, adding up to 200 cases of dengue fever with neurological manifestations. Relevant cases have been reported from
Asia, the Pacific rim, the Americas, the Mediterranean region, and Africa. A wide range of neurological manifestations has
been reported. Altered consciousness and seizure are among the more common manifestations. The exact pathogenesis of
this disease has not yet been established. However, recent studies hypothesize that the virus is neurotropic. Detection of
IgM in CSF using ELISA has a high specificity. Most patients usually recover fully, but some develop neurological sequelae.
Mortality ranges from 5-22% across the published literature. Dengue fever should be included in the differential diagnosis
of a person presenting with fever and neurological symptoms. This becomes especially important in endemic areas or during
epidemics in other areas.

Dengue is an arbovirus belonging to the flavivirus family. It
has four serotypes. They all have the mosquito Aedes
egypti as their principal vector. Incubation period of these
viruses ranges from 2-7 days after which they cause a
range of similar clinical syndromes.1 One hundred million
cases of dengue fever (DF) are reported yearly by the
World Health Organization (WHO), making it one of the
most important viral diseases in the world. WHO has
developed a set of criteria that are useful for the diagnosis
and grading of dengue infection (Table 1).
Dengue fever is also one of the leading causes of
hospitalization and death among children.2,3 Epidemics of
dengue are being seen in almost all countries located
within the tropical belt. 4 The increasing incidence of
flavivirus infection has been linked to resurgence of the
vector A. egypti, as well as to overcrowding and increasing
travel.4

mu st be kept in min d w he n e xplo ring caus es of
encephalitis and encephalopathy. For the purposes of this
article, we reviewed 9 original articles and 10 case reports
adding to a cumulative total of 200 cases of dengue fever
with CNS manifestations.

EPIDEMIOLOGY
Neurological disorders associated with DF have been
reported from 25 different countries representing AsiaPacific, the Americas, the Mediterranean and Africa. All
ages and both sexes are affected by the neurological
complications. Cases have been reported among ages
ranging from 3 months to 60 years.6 However, there is a
greater incidence among children.
The incidence of neurological symptoms among dengue
p at ient s var ied fr om 1 % t o 2 5% o f al l deng ue
a d m i s s i o n s . 4 , 6 , 7 In Indonesia, 70% of virologically
confirmed fatal dengue infections (n=30) presented with
one or more neurological signs, and 7% of those admitted
for viral encephalitis turned out to be dengue-infected.8 In
another study , 4.2% of patients with neuro logical
symptoms tested positive for dengue.4

The relationship between hemorrhagic dengue fever and
neurological manifestations was first described in 1976.
Since then there have been various case reports and
original articles published on this subject. In 1983, Gubler
and others recorded neurological disorders associated
with dengue from 25 different countries across Asia, the
Pacific rim, the Americas, Mediterranean regions, and
Africa.5 In dengue-endemic areas, this infectious agent
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TABLE.1
WHO criteria for making a diagnosis of DHF
It is a febrile illness with a platelet count of 100,000x 10e6/l or less and a
hematocrit raised 20% or more above the norm.
Grade 1: Positive tourniquet test is the only manifestation
Grade2: Spontaneous bleeding occurs
Grade 3 and 4 are referred to as dengue shock syndromes
Grade 3: narrowing of pulse pressure, circulatory failure and a rapid weak pulse
Grade 4: profound shock and no detectable pulse

TABLE. 2
Manifestations of Dengue infection
Name Of Journal
& Year

SEAJ Trop Med
1996(6)

Lancet
2000(4)

Am J Trop Med
Hyg2001(11)

SEAJ Trop Med
1999(13)

SEAJ Trop
Med(10)

Sample population

42 patients with DHF

383 patients with
suspected CNS
infection

5400 patients with DHF

30 serologically
confirmed dengue
patients with CNS
manifestations

1493
serologically
confirmed
dengue patients

Age

4yrs-60yrs

3 months-40yrs

8 months-15yrs

3 months-14yrs

3 months-14yrs

Number with CNS

20 21

27

30

a80

Neurological
manifestations
(%)

Altered sensorium ( 50)
Convulsion(70)
Decerebration Neck
rigidity. Altered
consciousness (30)

Reduced consciousness
(85.7)
Convulsions (43)
Spastic paraparesis
meningismus

Agitation
Generalized seizures
(77.8) Coma (96.3)
hemiplegia

Altered
consciousness (76.7)
Seizures (63.3)
Pyramidal tract
signs(36.7) Meningeal
signs(30)
Headache(26.7)

PATHOGENESIS

were due to metabolic changes rather than neurovirulence on the part of the etiological agent. Another
prospective11 case-control study found IgM antibodies to
dengue in 14 of 22 samples. This study suggests that
dengue virus itself has neuro-virulent properties. Clinical
studies have therefore established the neuro-virulent
properties of DEN-2 subtype dengue infection and DEN-3
subtype dengue infection.4,8,12,13

Enc ephalopathy is the most common neurological
manifestation. It may result from hypotension, cerebral
e dema , mi c ro va scula r a nd f rank he mo rr ha ge ,
hyponatremia, and fulminant hepatic failure which may be
part of Reye's Syndrome.4,9 These metabolic factors are
held responsible for neurological manifestations when the
virus or its serological evidence cannot be found in the
CSF. Two studies conducted in 2001 on neurological
ma nifes tat ions of den gue c ame t o tw o dif fer en t
co ncl usio ns a bo ut th e patho gene sis . O ne was a
retrospective study in which all the collected CSF samples
came out to be negative for IgM and PCR of dengue.10
This report suggested that the neurological symptoms

PAKI STAN

JOURN AL OF NEUROLOGICAL SCI ENCES

Altered
consciousness (44)
Seizures (67.5)

Many cases of true dengue encephalitis have been
r e p o r t e d . 1 2 , 1 6 An imal s tud ies have shown a virus mediated breakdown of the blood-brain barrier.4,11 In the
previous study, negative CSF results may be explained on
the basis that the encephalopathy resulted from metabolic
abnormalities. Also, titers are lower and shorter-lived in
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flaccid paraparesis19, transverse myelitis4, peripheral facial
p a r a l y s i s 1 9 , hemifacial spasm 2 0 , a Guilllain-Bar re
syndrome-like illness 12,18,21, tremors, manic psychosis,
depression, dementia8, pyramidal tract signs, amnesia22,
short-term memory loss23, decerebration24, and coma.

Immuno-histochemical studies in one case showed
infiltration of CD68+ macrophages after breakdown of the
blood brain barrier , suggesting that virus- infe cted
macrophages may be one of the pathways by which virus
enters the brain.14 More sensitive diagnostic measures
are needed for detecting presence of dengue infection in
CSF.

Acute hepatic failure has been reported as part of dengue
viral syndrome. Eighteen cases of dengue with liver failure
and hepatic encephalopathy were observed among 334
patients admitted to a hospital in Thailand25; survival rate
was 72%. In India, headache was reported in 34 and
drowsiness in 28 in a prospective study based on a total of
59 c hild re n sero-posi tiv e for d engue 2 6 . M ost
manifestations were observed during the febrile stage, and
few have been reported afterwards. In 5 studies reporting a
total of 355 Southeast Asian cases of DF associated with
symptoms of encephalitis (see Table 2), 47% were drowsy
and 21% had seizures.15,9,10,21,22,23

In 1993, two cases were reported in Thailand and New
Caledonia. One patient developed focal subarachnoid
hemorrhage, while the second patient showed peripheral
facial palsy one week after fever onset. In neither case
was viral presence or serological evidence of infection
detected in CSF. It was suggested this may have been
due to immuno-pathological consequences secondary to
dengue.18
Encephalitis can only be said to have occurred when a
histological diagnosis is available. 4,10 Several studies,
however, have based diagnosis of encephalitis on indirect
evidence, including absence of other explanations for
encephalopathy, isolation of virus in CSF or its serological
evidence, CSF pleocytosis, or focal neurological signs.4
Den3 serotype is especially thought to have neurovirulent
p r o p e r t i e s . 6 , 7 , 9 However, in various studies different
serotypes have been isolated - Den1 serotype in a series
from Rio de Janeiro11 and Den2 serotype in cortical grey
matter by immuno-histochemistry. 9,12 It is difficult to
explain the presence of dengue viruse and IgM antibody
other than by viral invasion across the blood brain
barrier.11

LABORATORY FINDINGS
Laboratory findings seen in dengue with CNS involvement
are provided in Table 3. Other laboratory observations
include high CSF opening pressure, CSF protein above
45mg/dL, peripheral leukocytosis, leucopenia 1 1 , and
increased prothrombin time.11,21

DIAGNOSIS
Antibodies to dengue virus can be detected in the serum
one day after onset of symptoms.17 Titer of antibodies in
serum usually persists for 30-90 days, although it has
been reported to be detectable as long as 252 days after
o n s e t . 1 7 Thus it is possible that a dengue infection
recognized as recent on the basis of IgM sero-diagnosis
may in fact be 8 months old. Anitbodies in the CSF,
however, usually disappear within a month after onset of
i l l n e s s 1 7 , a nd ar e un de te ctable e ve n with
hemagglutination-inhibition testing.17 ELISA appears to be
more sensitive for detecting antibodies in the CSF.13

In some studies, post mortem examination of brain tissue
has revealed the presence of dengue virus.13,14 Given lack
of evidence supporting viral invasion of the CNS, the term
encephalopathy instead of encephalitis has been used.
Othe r m em be rs of the Fla vi virid ae family in clude
neurotropic viruses causing Japanese encephalitis, Murray
Valley encephalitis, West Nile encephalitis, St. Louis
encephalitis, and yellow fever. In recent years, evidence
has been gathered to show that dengue viruses can cause
infection of the CNS;12,17 Den2 and 3, especially, can
cause dengue encephalitis in the form of both primary and
secondary infections.12

PROGNOSIS
Mortality rates vary from 5%10 to 22%.11 Causes of death
include multi-organ failure 12, hemorrhagic complications,
and circulatory collapse 1 9. Most patients completely
recover by the time of hospital discharge. 8,10,12,13,24
Neurological sequelae include spastic paresis, static
myelopathy follo win g trans ve rse m yelit is, residu al
spasticity, prolonged drowsiness, residual paralysis12 and
Parkinsonian syndrome. 1 4 Abnormal affect, altered

CLINICAL MANIFESTATIONS
Some dengue patients manifesting neurological symptoms
may not show any characteristic features of dengue fever
on admission.4 Diverse manifestations are reported in the
literature, including depressed sensorium, convulsions,
behavioral disorder, nuchal rigidity12, positive Kerning's sign
and Brudzinski reflex, focal neurological deficits9,10, 12,
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TABLE. 3
Laboratory findings in patients with dengue
Name Of Journal
& Year

SEAJ Trop Med
1996

Lancet
2000

Am J Trop Med
Hyg2001

SEAJ Trop Med
1999

SEAJ Trop
Med 2001

CSF findings

2 IgM Dengue +ve

2 virus isolated
3 PCR +ve
3 IgM Dengue +ve

1 PCR +ve
14 IgM Dengue +ve

2 IgM Dengue +ve

PCR -ve no virus
isolated

CSF Pleocytosis

3

Not present

6

7

Liver transaminases

More than 10 times
above normal in 5

significantly elevated
in all 27 of the
patients in the study
group

AST > 50 in 19
patients
ALT >50 in 17
patients

Hyponatremia

6

27

54

TABLE. 4
Prognosis of dengue patients
Name Of Journal
& Year

SEAJ Trop Med
1996

Lancet
2000

Am J Trop Med
Hyg2001

SEAJ Trop Med
1999

SEAJ Trop
Med 2001

Outcome

1 expired
4 recovered
data about others
missing

15 fully recovered
between 2-20 days
6 neurological
sequelae at discharge

6 expired
21 fully recovered
within a maximum
of 7 days

2 expired rest had
uneventful recovery

4 expired
1 long term
neurological
sequelae

CONCLUSION
Dengue viral infection is emerging as an important cause
of CNS symptoms. It may cause encephalopathy or
encephalitis. Studies suggest that dengue infection should
be con sidered in ca ses of encephalitis in tro pica l
countries, especially where the disease is endemic.14 Due
to diverse and protean manifestations, a low threshold for
diagnostic suspicion is required.
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